NLS Pharmaceutics AG (NLSPW) — Financial Flexibility Index
Latest as of September 2025:
-1.43x
NLS Pharmaceutics AG (NLSPW) has a Financial Flexibility Index of -1.43x as of September 2025. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $0.00) represents -1% of total liabilities ($1.46 Million).
Financial Flexibility Index
-1.43x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-2.07 Million
Operating CF − Capex
Total Liabilities
$1.46 Million
USD
Capital Expenditures
$0.00
USD
NLS Pharmaceutics AG Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NLS Pharmaceutics AG across 8 annual periods. See NLS Pharmaceutics AG current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for NLS Pharmaceutics AG (2017–2024)
Year-by-year free cash flow to debt coverage for NLS Pharmaceutics AG. For the full company profile including market capitalisation, see NLSPW market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.16x | $-4.26 Million | $-4.27 Million | $826.76K | ▼ -468.8% |
| 2023 | -0.91x | $-9.68 Million | $-9.68 Million | $10.68 Million | ▲ +58.9% |
| 2022 | -2.21x | $-13.24 Million | $-13.88 Million | $6.00 Million | ▲ +22.6% |
| 2021 | -2.85x | $-14.90 Million | $-14.94 Million | $5.22 Million | ▼ -3887.3% |
| 2020 | -0.07x | $-729.38K | $-729.39K | $10.20 Million | ▼ -158.6% |
| 2019 | -0.03x | $-190.01K | $-190.01K | $6.87 Million | ▲ +90.9% |
| 2018 | -0.31x | $-2.73 Million | $-2.73 Million | $8.96 Million | ▲ +43.8% |
| 2017 | -0.54x | $-5.43 Million | $-5.43 Million | $10.01 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities